Revised national protocol for COVID-19 mRNA vaccine BNT162b2 (Pfizer/BioNTech)

Various amendments have been made to the protocol (listed on page 2). It now allows for stage 2 to be undertaken by persons under the supervision of a doctor, nurse or pharmacist, for vaccination of breastfeeding women, and updated exclusion criteria, among others.

Public Health England